Search

Search Constraints

You searched for: Author/Creator Tarella, C.

Search Results

1. CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HODGKIN LYMPHOMA WITH LARGE NODAL MASS IN COMPLETE METABOLIC RESPONSE AFTER ABVD. FINAL ANALYSIS OF THE RANDOMIZED HD0607 TRIAL. (12th June 2019)

3. INTEGRATING TUMOR‐ AND MICROENVIRONMENT‐REFLECTING GENES IN A UNIQUE AND ROUTINE‐APPLICABLE ASSAY FOR ACCURATE RISK PREDICTION IN DLBCL. (12th June 2019)

4. International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20‐Positive B Cell PTLD: Clues From the PTLD‐1 Trial. Issue 4 (3rd March 2015)

5. Minced Umbilical Cord Fragments as a Source of Cells for Orthopaedic Tissue Engineering: An In Vitro Study. (7th March 2012)

6. Monocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP‐43 subcellular distribution. (28th June 2016)

7. P1123: TEMPO: A PHASE 2, RANDOMIZED, OPEN-LABEL, 2-ARM STUDY COMPARING TWO INTERMITTENT DOSING SCHEDULES OF DUVELISIB IN SUBJECTS WITH INDOLENT NON-HODGKIN LYMPHOMA (INHL). (23rd June 2022)

8. PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN. (23rd June 2022)

9. PREDICTIVE VALUE OF END‐OF‐TREATMENT POSITRON EMISSION TOMOGRAPHY SCAN AFTER DA‐EPOCH‐R IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA. REAL‐LIFE EXPERIENCE. (12th June 2019)

10. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma. Issue 3 (March 2016)